SBA
IBB icon

Secrest Blakey & Associates’s iShares Biotechnology ETF IBB Stock Holding History

Secrest Blakey & Associates’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-80
Closed -$8K – 82
2019
Q3 		$8K Hold
80
– – 0.01% 126
2019
Q2 		$9K Hold
80
– – 0.01% 122
2019
Q1 		$9K Buy
+80
New +$8.78K 0.01% 113

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Secrest Blakey & Associates's IBB Position: Q4 2019 in Review

Secrest Blakey & Associates sold out of iShares Biotechnology ETF (IBB) in Q4 2019, closing a stake of 80 shares — an estimated $8K sold.

Secrest Blakey & Associates first reported a position in IBB in Q1 2019 and held it in 3 quarters. The position peaked at $9K in Q2 2019. 710 funds tracked by Wall St. Rank hold IBB as of Q4 2019.

  • Secrest Blakey & Associates reported no remaining iShares Biotechnology ETF position as of Q4 2019 after selling out during the quarter.
  • Secrest Blakey & Associates sold 80 iShares Biotechnology ETF shares in Q4 2019, an estimated $8K.
  • Secrest Blakey & Associates first reported a position in iShares Biotechnology ETF in Q1 2019 and held it in 3 quarters.
  • Secrest Blakey & Associates's iShares Biotechnology ETF position peaked at $9K in Q2 2019.
  • 710 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2019.

Based on Secrest Blakey & Associates's 13F filing for Q4 2019, filed 5 Feb 2020.